Getting a Leg Up on Knee Cartilage Repair with ProChon Biotech

ProChon’s lead product is BioCart, a second-generation tissue regeneration implant for the treatment of joint cartilage defects and injuries.

Read more »

Ortho Kinematics Pursues Large Market Opportunity in Back Pain Diagnostics

Although back pain is common, it can be difficult for physicians to determine the exact cause of the pain using current testing methods.

Read more »

New World Laboratories Forges Ahead with Novel Regenerative Therapeutics

NWL seeks to prevent degeneration and restore function in damaged tissue, particularly in the nervous system.

Read more »

Novadaq SPYs on Patient Health During Surgical Procedures

Novadaq Technologies (TSX: NDQ) develops and markets real-time fluorescence imaging technologies for use in the operating room.

Read more »

NeoVista’s Sights Remain On Underserved AMD Market

The administration of the device plus the administration of as-needed anti-VEGF therapy is showing promising results.

Read more »

Growing Regenerative Medicine Market Provides Opportunities for Cytori Therapeutics

For many breast cancer patients, the effects of undergoing a mastectomy go well beyond the physical.

Read more »

DataPhysics Research Aims to Streamline Workflow Process for Busy Radiologists

The Danville, Calif.-based company offers CaseReader, a software solution that is designed to deliver faster, more accurate analysis of image scans.

Read more »

Market for Incontinence Products, Therapies Expected to Grow

Advances in medicine have allowed people in developed countries to live longer, but at a cost: An increased lifespan raises a patient’s likelihood of developing health issues such as angina or incontinence.

Read more »

IntelleWave Seeks to Improve Patient Care Through Cardiac Analysis

If your body’s autonomic nervous system (ANS) is working properly, you probably won’t notice it.

Read more »

The Ambitious Pipeline of EpiCept Corporation

EpiCept’s lead product, Ceplene, is approved for marketing in the EU for the maintenance of first remission in patients with acute myeloid leukemia.

Read more »